Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Rich New Stem Cell Source: Research on Umbilical Cord Matrix

27.09.2004


Stem cell research. Just the mention of the controversial study stirs up a storm of debate.

The divisive research has become a political hot potato, even emerging as a campaign issue. One presidential candidate has declared it an ethical and moral issue that must not be treated lightly; the other has pledged to lift a partial ban on the research. In California, voters will vote on a measure that would devote $3 billion to human embryonic stem cell experiments.

Even a prominent political family has been split down the middle with regard to the importance of embryonic stem cell research, because it is believed by many that a fertilized embryo constitutes a human being.



A Kansas State University professor of anatomy and physiology has spent his life as a researcher and scientist focusing on genetic neurologic conditions, gene mapping and the use of chromosomal microdissection to generate DNA markers. Recently, the emphasis of Deryl Troyer’s laboratory has shifted to stem cell biotechnology.

Troyer is particularly interested in developing stem cells as a source of replacement cells for somatic cells damaged or lost due to degenerative disease, trauma or aging and their use in targeted delivery of therapeutic peptides or proteins. He has discovered, along with colleagues Mark Weiss, professor of anatomy and physiology in K-State’s College of Veterinary Medicine and Duane Davis, a professor of animal sciences and industry, a novel and potentially inexhaustible source of stem cells isolated from the matrix of umbilical cords.

These cells have a remarkable propensity to develop into neural stem cells. He is presently collaborating in studies to further characterize these cells and develop them for stem cell therapies in animals and humans. Recent work indicated that these stem cells can be xenotransplanted into the brain without being rejected and that they differentiated into neurons.

The cushioning material or matrix within the umbilical cord known as Wharton’s jelly is a rich and readily available source of primitive stem cells, according to findings by Troyer and Weiss. Animal and human umbilical cord matrix cells exhibit the tell-tale characteristics of all stem cells, the capacity to self-renew and to differentiate into multiple cell types.

The cells -- called cord matrix stem cells to distinguish them from cord blood cells -- can be obtained in a non-invasive manner from an abundant source of tissue that is typically discarded. "Unfortunately, people hear the term stem cells and they automatically conclude that it is coming from an embryonic source," Weiss said. "That is an unfortunate connotation that is not always accurate."

According to Weiss and Troyer, "Umbilical cord matrix cells could provide the scientific and medical research community with a non-controversial and easily attainable source of stem cells for developing treatments for Parkinson’s disease, stroke, spinal cord injuries, cancers and other conditions."

The discovery of the matrix stem cells may also lead to important new technologies in animal agriculture and for the preservation of endangered species. Among the group’s findings: Wharton’s jelly cells from pigs were propagated in the lab for more than a year without losing potency; they can be stored cryogenically and engineered to express foreign proteins.

The cells exhibit telomerase activity, a key indicator of stem cells, and they can be induced to form nerve cells, both neurons and glia, that produce a range of nerve-cell specific traits. Neurons are the nervous system cells that transmit signals; glial cells support the neurons. On the basis of the encouraging results with animal tissue, the team broadened its investigations to human umbilical cord matrix cells with similar exciting findings -- human umbilical cord matrix cells differentiate into neurons, too.

Most of the promise of developing embryonic stem cell-based therapies for treating several degenerative diseases of the nervous system as well as other types of disease is hindered by the controversial nature of the cell sources. Research progress has also been slowed by having a limited number of existing embryonic stem cell lines available for federally-funded medical research. "Identifying a non-controversial source of primitive stem cells is a step in the right direction," Davis said.

Wharton’s jelly, discovered in the mid-1600s by Thomas Wharton, a London physician, is the gelatinous connective tissue only found in the umbilical cord. The jelly gives the cord resiliency and pliability, and protects the blood vessels in the umbilical cord from compression.

As an embryo forms, some very primitive cells migrate between the region where the umbilical cord forms and the embryo. Some primitive cells just might remain in the matrix later in gestation or still be there even after the baby is born. The K-State research team suggests that Wharton’s jelly might be a reservoir of the primitive stem cells that form soon after the egg is fertilized. "Our results indicate that Wharton’s jelly cells can be expanded in vitro, maintained in culture and induced to differentiate into cells that express several proteins found in neural cells, and thus may be beneficial in diseases where neurons die," Troyer said. We think these cells can serve many therapeutic and biotechnological roles in the future."

The team now is evaluating human umbilical cord matrix cells to see if in addition to forming nerve tissues the cells also will differentiate into cardiac muscle and the cells that line the blood vessels. They note that important progress is being made in the Weiss and Troyer labs where the researchers are looking at the ability of the umbilical cord matrix cells to form new neurons in the brain, which would aid against Parkinson’s disease.

The KSU Research Foundation has filed for U.S. patent protection for the recent discoveries, the method of culturing the stem cells, and a kit for salvaging umbilical cord stem cells after birth. Funding for this research has come from the National Institutes of Health, a Centers of Biomedical Research Excellence/COBRE award to the University of Kansas, with matching support from the state of Kansas, Kansas State University, University of Kansas, the Terry C. Johnson Cancer Center, the K-State College of Veterinary Medicine and the Kansas Agricultural Experiment Station.

For patent and commercialization information, contact the National Institute for Strategic Technology Acquisition and Commercialization, 785-532-3900. For more about stem cells, see the National Institutes of Health primer at http://www.nih.gov/news/stemcell/primer.htm

| newswise
Further information:
http://www.nih.gov
http://www.mediarelations.k-state.edu/WEB/News/MediaGuide/dtroyerbio.html
http://www.mediarelations.k-state.edu/WEB/News/MediaGuide/mweissbio.html

More articles from Life Sciences:

nachricht Cloud Formation: How Feldspar Acts as Ice Nucleus
09.12.2016 | Karlsruher Institut für Technologie

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>